Profound Medical Announces Non-Brokered Private Placement
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company“) is pleased to announce that the Company has entered into subscription agreements, dated as of January 16, 2024, with certain existing Canadian institutional investors, in connection with a non-brokered private placement (the “Private Placement“) for aggregate gross proceeds of approximately US$2,937,502.
Related news for (PROF)
- Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
- Profound Medical Annual General and Special Meeting of Shareholders Voting Results
- Profound Medical AUA 2025 Investor Event Agenda
- Save the Date: Profound Medical to Host Investor Event at AUA 2025
- Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results